Summary
Intellectual property and patents shape corporate growth, credibility and profitability, but the litigation associated with IP and patents is known for its high cost, complexity and duration. In 2021, IP and patent litigation stakes were heightened by disputes related to Covid vaccine development and a spate of nine-figure mega-verdicts across industries. While it’s not news that patent litigation can result in very sizeable monetary damages, the uptick in activity nonetheless drew headlines.
Patent holders will turn to divestitures to indirectly monetize corporate patent portfolios
Often, operating companies and universities with patent portfolios have business conflicts or reputational concerns that prevent them from pursuing affirmative litigatio…